208 related articles for article (PubMed ID: 24694581)
1. Do patients with chronic kidney disease get optimal cardiovascular risk reduction?
Elliott MK; McCaughan JA; Fogarty DG
Curr Opin Nephrol Hypertens; 2014 May; 23(3):267-74. PubMed ID: 24694581
[TBL] [Abstract][Full Text] [Related]
2. Chronic renal disease and risk of cardiovascular morbidity-mortality.
Santoro A; Mandreoli M
Kidney Blood Press Res; 2014; 39(2-3):142-6. PubMed ID: 25117863
[TBL] [Abstract][Full Text] [Related]
3. Multifactorial intervention with nurse practitioners does not change cardiovascular outcomes in patients with chronic kidney disease.
van Zuilen AD; Bots ML; Dulger A; van der Tweel I; van Buren M; Ten Dam MA; Kaasjager KA; Ligtenberg G; Sijpkens YW; Sluiter HE; van de Ven PJ; Vervoort G; Vleming LJ; Blankestijn PJ; Wetzels JF
Kidney Int; 2012 Sep; 82(6):710-7. PubMed ID: 22739979
[TBL] [Abstract][Full Text] [Related]
4. The MAURO study: baseline characteristics and compliance with guidelines targets.
Leonardis D; Mallamaci F; Enia G; Postorino M; Tripepi G; Zoccali C;
J Nephrol; 2012; 25(6):1081-90. PubMed ID: 23172127
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular disease and its relationship with chronic kidney disease.
Liu M; Li XC; Lu L; Cao Y; Sun RR; Chen S; Zhang PY
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2918-26. PubMed ID: 25339487
[TBL] [Abstract][Full Text] [Related]
6. Effect of pravastatin in people with diabetes and chronic kidney disease.
Tonelli M; Keech A; Shepherd J; Sacks F; Tonkin A; Packard C; Pfeffer M; Simes J; Isles C; Furberg C; West M; Craven T; Curhan G
J Am Soc Nephrol; 2005 Dec; 16(12):3748-54. PubMed ID: 16251235
[TBL] [Abstract][Full Text] [Related]
7. Physiological benefits of exercise in pre-dialysis chronic kidney disease.
Gould DW; Graham-Brown MP; Watson EL; Viana JL; Smith AC
Nephrology (Carlton); 2014 Sep; 19(9):519-27. PubMed ID: 24899042
[TBL] [Abstract][Full Text] [Related]
8. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
9. Risk prediction in chronic kidney disease: pitfalls and caveats.
Rigatto C; Sood MM; Tangri N
Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):612-8. PubMed ID: 23042027
[TBL] [Abstract][Full Text] [Related]
10. HMG-CoA reductase inhibitors in chronic kidney disease.
Olyaei A; Steffl JL; MacLaughlan J; Trabolsi M; Quadri SP; Abbasi I; Lerma E
Am J Cardiovasc Drugs; 2013 Dec; 13(6):385-98. PubMed ID: 23975627
[TBL] [Abstract][Full Text] [Related]
11. Arterial stiffness in chronic kidney disease: an update.
Taal MW
Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):169-73. PubMed ID: 24389732
[TBL] [Abstract][Full Text] [Related]
12. What should be the goal blood pressure in nondiabetic chronic kidney disease?
Schneider MP; Hilgers KF
Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):180-5. PubMed ID: 24401787
[TBL] [Abstract][Full Text] [Related]
13. Cardiorenal interaction: appropriate treatment of cardiovascular risk factors to improve outcomes in chronic kidney disease.
McCullough PA; Verrill TA
Postgrad Med; 2010 Mar; 122(2):25-34. PubMed ID: 20203453
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers in native and transplant kidneys: opportunities to improve prediction of outcomes in chronic kidney disease.
De Serres SA; Varghese JC; Levin A
Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):619-27. PubMed ID: 22914685
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease in chronic kidney disease in 2015.
Sud M; Naimark DM
Curr Opin Nephrol Hypertens; 2016 May; 25(3):203-7. PubMed ID: 27023835
[TBL] [Abstract][Full Text] [Related]
16. Recognizing the link between CKD and CVD in the primary care setting: accurate and early diagnosis for timely and appropriate intervention.
Basile JN
South Med J; 2007 May; 100(5):499-505. PubMed ID: 17534087
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
18. Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality?
Abaterusso C; Pertica N; Lupo A; Ortalda V; Gambaro G
Diabetes Obes Metab; 2008 Sep; 10(10):843-9. PubMed ID: 18093210
[TBL] [Abstract][Full Text] [Related]
19. Cigarette use and cardiovascular risk in chronic kidney disease: an unappreciated modifiable lifestyle risk factor.
Stack AG; Murthy BV
Semin Dial; 2010; 23(3):298-305. PubMed ID: 20636923
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, awareness, and management of CKD and cardiovascular risk factors in publicly funded health care.
Verhave JC; Troyanov S; Mongeau F; Fradette L; Bouchard J; Awadalla P; Madore F
Clin J Am Soc Nephrol; 2014 Apr; 9(4):713-9. PubMed ID: 24458079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
